Genomics Market In US 2026-2030
Description
Genomics Market In US 2026-2030
The genomics market in us is forecasted to grow by USD 9246.2 mn during 2025-2030, accelerating at a CAGR of 12.9% during the forecast period. The report on the genomics market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in next generation sequencing and bioinformatics integration, increasing demand for creating and upgrading genome databases, integration of ai and ml in genomic data analysis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's genomics market in us is segmented as below:
By Application
The report on the genomics market in us covers the following areas:
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
The genomics market in us is forecasted to grow by USD 9246.2 mn during 2025-2030, accelerating at a CAGR of 12.9% during the forecast period. The report on the genomics market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in next generation sequencing and bioinformatics integration, increasing demand for creating and upgrading genome databases, integration of ai and ml in genomic data analysis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's genomics market in us is segmented as below:
By Application
- Diagnostics
- Drug discovery
- Others
- Hospitals and clinics
- Academics and research institutes
- Pharmaceuticals and biotechnology companies
- Others
- Products
- Services
- North America
- US
The report on the genomics market in us covers the following areas:
- Genomics market in us sizing
- Genomics market in us forecast
- Genomics market in us industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
187 Pages
- 1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Company Market Positioning
- 2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
- 4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US: Year-over-year growth 2025-2030 (%)
- Data Table on US: Year-over-year growth 2025-2030 (%)
- 5 Historic Market Size
- 5 Historic Market Size
- 5.1 Genomics Market in US 2020 - 2024
- Historic Market Size - Data Table on Genomics Market in US 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)
- 6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 The AI impact on Genomics Market in US
- 7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030
- 8 Market Segmentation by Application
- 8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Diagnostics - Market size and forecast 2025-2030
- Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
- 8.4 Drug discovery - Market size and forecast 2025-2030
- Chart on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Data Table on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Chart on Drug discovery - Year-over-year growth 2025-2030 (%)
- Data Table on Drug discovery - Year-over-year growth 2025-2030 (%)
- 8.5 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
- 9 Market Segmentation by End-user
- 9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Hospitals and clinics - Market size and forecast 2025-2030
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- 9.4 Academics and research institutes - Market size and forecast 2025-2030
- Chart on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
- Data Table on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
- Chart on Academics and research institutes - Year-over-year growth 2025-2030 (%)
- Data Table on Academics and research institutes - Year-over-year growth 2025-2030 (%)
- 9.5 Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030
- Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
- Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
- Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
- Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
- 9.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
- 10 Market Segmentation by Solution
- 10 Market Segmentation by Solution
- 10.1 Market segments
- Chart on Solution - Market share 2025-2030 (%)
- Data Table on Solution - Market share 2025-2030 (%)
- 10.2 Comparison by Solution
- Chart on Comparison by Solution
- Data Table on Comparison by Solution
- 10.3 Products - Market size and forecast 2025-2030
- Chart on Products - Market size and forecast 2025-2030 ($ million)
- Data Table on Products - Market size and forecast 2025-2030 ($ million)
- Chart on Products - Year-over-year growth 2025-2030 (%)
- Data Table on Products - Year-over-year growth 2025-2030 (%)
- 10.4 Services - Market size and forecast 2025-2030
- Chart on Services - Market size and forecast 2025-2030 ($ million)
- Data Table on Services - Market size and forecast 2025-2030 ($ million)
- Chart on Services - Year-over-year growth 2025-2030 (%)
- Data Table on Services - Year-over-year growth 2025-2030 (%)
- 10.5 Market opportunity by Solution
- Market opportunity by Solution ($ million)
- Data Table on Market opportunity by Solution ($ million)
- 11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 12 Drivers, Challenges, and Opportunity
- 12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Technological innovations in next generation sequencing and bioinformatics integration
- Increasing demand for creating and upgrading genome databases
- Integration of AI and ML in genomic data analysis
- 12.2 Market challenges
- Data security and regulatory compliance issues
- Reimbursement hurdles and economic disparities
- Clinical integration and workforce shortages
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 12.4 Market opportunities
- Acceleration of precision medicine and targeted oncology clinical integration
- Advances in sequencing technologies
- Growing applications of genomics in oncology
- 13 Competitive Landscape
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
- 14 Competitive Analysis
- 14 Competitive Analysis
- 14.1 Companies profiled
- Companies covered
- 14.2 Company ranking index
- Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 14.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 14.6 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 14.7 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 14.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 14.9 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 14.10 LetsGetChecked
- LetsGetChecked - Overview
- LetsGetChecked - Product / Service
- LetsGetChecked - Key offerings
- SWOT
- 14.11 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- SWOT
- 14.12 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Product / Service
- Natera Inc. - Key news
- Natera Inc. - Key offerings
- SWOT
- 14.13 Oxford Nanopore Technologies
- Oxford Nanopore Technologies - Overview
- Oxford Nanopore Technologies - Product / Service
- Oxford Nanopore Technologies - Key offerings
- SWOT
- 14.14 Pacific Biosciences Inc.
- Pacific Biosciences Inc. - Overview
- Pacific Biosciences Inc. - Product / Service
- Pacific Biosciences Inc. - Key news
- Pacific Biosciences Inc. - Key offerings
- SWOT
- 14.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- 14.16 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 14.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 14.18 Twist Bioscience Corp.
- Twist Bioscience Corp. - Overview
- Twist Bioscience Corp. - Product / Service
- Twist Bioscience Corp. - Key offerings
- SWOT
- 15 Appendix
- 15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- Research methodology
- 15.5 Data procurement
- Information sources
- 15.6 Data validation
- Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
- List of abbreviations
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Country Market Characteristics
- Exhibits4: Executive Summary - Chart on Market Segmentation by Application
- Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
- Exhibits7: Executive Summary - Chart on Company Market Positioning
- Exhibits8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits9: Overview on criticality of inputs and factors of differentiation
- Exhibits10: Overview on factors of disruption
- Exhibits11: Impact of drivers and challenges in 2025 and 2030
- Exhibits12: Chart on Parent Market
- Exhibits13: Data Table on - Parent Market
- Exhibits14: Chart on Market characteristics analysis
- Exhibits15: Chart on Value chain analysis
- Exhibits16: Data Table on Offerings of companies included in the market definition
- Exhibits17: Market segments
- Exhibits18: Chart on US - Market size and forecast 2025-2030 ($ million)
- Exhibits19: Data Table on US - Market size and forecast 2025-2030 ($ million)
- Exhibits20: Chart on US: Year-over-year growth 2025-2030 (%)
- Exhibits21: Data Table on US: Year-over-year growth 2025-2030 (%)
- Exhibits22: Historic Market Size - Data Table on Genomics Market in US 2020 - 2024 ($ million)
- Exhibits23: Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Exhibits24: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Exhibits25: Historic Market Size - Solution Segment 2020 - 2024 ($ million)
- Exhibits26: Five forces analysis - Comparison between 2025 and 2030
- Exhibits27: Bargaining power of buyers - Impact of key factors 2025 and 2030
- Exhibits28: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Exhibits29: Threat of new entrants - Impact of key factors in 2025 and 2030
- Exhibits30: Threat of substitutes - Impact of key factors in 2025 and 2030
- Exhibits31: Threat of rivalry - Impact of key factors in 2025 and 2030
- Exhibits32: Chart on Market condition - Five forces 2025 and 2030
- Exhibits33: Chart on Application - Market share 2025-2030 (%)
- Exhibits34: Data Table on Application - Market share 2025-2030 (%)
- Exhibits35: Chart on Comparison by Application
- Exhibits36: Data Table on Comparison by Application
- Exhibits37: Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Exhibits38: Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Exhibits39: Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
- Exhibits40: Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
- Exhibits41: Chart on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Exhibits42: Data Table on Drug discovery - Market size and forecast 2025-2030 ($ million)
- Exhibits43: Chart on Drug discovery - Year-over-year growth 2025-2030 (%)
- Exhibits44: Data Table on Drug discovery - Year-over-year growth 2025-2030 (%)
- Exhibits45: Chart on Others - Market size and forecast 2025-2030 ($ million)
- Exhibits46: Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Exhibits47: Chart on Others - Year-over-year growth 2025-2030 (%)
- Exhibits48: Data Table on Others - Year-over-year growth 2025-2030 (%)
- Exhibits49: Market opportunity by Application ($ million)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

